ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,526.50
-0.29%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. ResMed Inc (RMD)

  7. ResMed Inc (RMD) Noticias

RMD

ResMed (RMD)

ResMed Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:RMD
FechaHoraFuenteTítuloSímboloCompañía
24/05/202411:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RMDResMed Inc
23/05/202408:05GlobeNewswire Inc.Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure TherapyNYSE:RMDResMed Inc
22/05/202413:51Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:RMDResMed Inc
16/05/202415:35GlobeNewswire Inc.ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP TherapyNYSE:RMDResMed Inc
16/05/202407:05GlobeNewswire Inc.MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data AccessNYSE:RMDResMed Inc
15/05/202409:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:RMDResMed Inc
07/05/202415:05GlobeNewswire Inc.ResMed Announces Participation in the RBCCM Global Healthcare ConferenceNYSE:RMDResMed Inc
25/04/202415:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
04/04/202415:05GlobeNewswire Inc.ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024NYSE:RMDResMed Inc
15/03/202402:05GlobeNewswire Inc.ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep CrisisNYSE:RMDResMed Inc
06/03/202408:05GlobeNewswire Inc.Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP MaskNYSE:RMDResMed Inc
12/02/202415:16GlobeNewswire Inc.ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep ApneaNYSE:RMDResMed Inc
07/02/202407:05GlobeNewswire Inc.MatrixCare Earns Three 2024 Best in KLAS AwardsNYSE:RMDResMed Inc
29/01/202405:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest newsNYSE:RMDResMed Inc
29/01/202405:09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street HighlightsNYSE:RMDResMed Inc
25/01/202412:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:RMDResMed Inc
24/01/202415:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:RMDResMed Inc
24/01/202415:05GlobeNewswire Inc.ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
03/01/202415:05GlobeNewswire Inc.ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024NYSE:RMDResMed Inc
27/12/202315:05GlobeNewswire Inc.ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:RMDResMed Inc
20/12/202315:05GlobeNewswire Inc.ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical DevicesNYSE:RMDResMed Inc
11/12/202315:05GlobeNewswire Inc.ResMed Secures Significant Victory in Patent Fight Against New York UniversityNYSE:RMDResMed Inc
07/12/202314:34GlobeNewswire Inc.Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients GloballyNYSE:RMDResMed Inc
09/11/202315:05GlobeNewswire Inc.ResMed Adopts New Operating Model to Accelerate Long-term GrowthNYSE:RMDResMed Inc
26/10/202315:05GlobeNewswire Inc.ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024NYSE:RMDResMed Inc
13/10/202316:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:RMDResMed Inc
10/10/202306:02IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNYSE:RMDResMed Inc
05/10/202315:05GlobeNewswire Inc.ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023NYSE:RMDResMed Inc
05/10/202313:48Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:RMDResMed Inc
05/10/202313:45Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:RMDResMed Inc
 Showing the most relevant articles for your search:NYSE:RMD

Su Consulta Reciente

NYSE
AXP
American Express
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados